Shanghai Fosun Pharmaceutical's (SHA:600196, HKG:2196) total routine transaction for the first nine months of the year reached 132.7 million yuan, according to a Shanghai bourse disclosure on Saturday.
The pharmaceutical company's Hong Kong shares rose over 1% during Monday's afternoon trade.
The transactions include sales, provision and acceptance of services from related parties, leasing services and donations through related parties.
The estimated cap for the current year is 342.4 million yuan, while that for 2026 is 366.5 million yuan.